Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora
Clinical trial NCT04366089 · UNKNOWN
Trial details
- NCT number
- NCT04366089
- Sponsor
- Roberto Poscia MD, PhD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-26
- Primary completion
- 2020-10-30
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.